Cara Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Good morning, everyone. My name is Daniel Wolle. I'm one of the analysts on this mid-cap biotech team. It's my pleasure to introduce Chris Posner from Cara Therapeutics. Following his presentation, rest of management will come up to the -- from podium. You can ask questions or you can ask through the portal as well.
Without further idea, Chris?
Well, thank you, Daniel, and good morning, everyone. And before we dig in quickly on Slide 2, just a necessary reminder of our forward-looking statements in this presentation, and you could refer to this, and you could also refer to our filings, our regulatory filings on our website.
So let's dig in. What's our mission? Our mission at Cara is to be the world leader when it comes to the treatment of pruritus. Now pruritus is more than just a niche. It's a significantly debilitating condition, and it really impacts a patient's quality of life. And despite
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
